Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Journal of Cellular Physiology
|
July 25, 2015
The PPARβ/δ Agonist GW0742 Induces Early Neuronal Maturation of Cortical Post-Mitotic Neurons: Role of PPARβ/δ in Neuronal Maturation
Elisabetta Benedetti, Silvia Di Loreto, Barbara D'Angelo, et al.
International Journal of Hematology
|
January 18, 2026
Three-year follow-up of epcoritamab therapy in Japanese patients with relapsed/refractory follicular lymphoma in EPCORE NHL-3
Koji Izutsu, Daigo Akahane, Tomomi Toubai, et al.
Leukemia & Lymphoma
|
July 9, 2025
Subcutaneous epcoritamab monotherapy in Japanese patients with relapsed or refractory follicular lymphoma: primary results of the EPCORE NHL-3 trial
Koji Izutsu, Daigo Akahane, Tomomi Toubai, et al.
Journal of Cellular Physiology
|
May 13, 2016
Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs
Annamaria Cimini, Michele d'Angelo, Elisabetta Benedetti, et al.
International Journal of Clinical Oncology
|
May 28, 2025
Efficacy and safety of epcoritamab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma: 3-year follow-up from the EPCORE NHL-3 trial
Koji Izutsu, Takahiro Kumode, Junichiro Yuda, et al.
Annals of Hematology
|
February 3, 2026
Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial
Yasmin H Karimi, Chan Y Cheah, Michael Roost Clausen, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Journal of Cellular Physiology
|
July 25, 2015
The PPARβ/δ Agonist GW0742 Induces Early Neuronal Maturation of Cortical Post-Mitotic Neurons: Role of PPARβ/δ in Neuronal Maturation
Elisabetta Benedetti, Silvia Di Loreto, Barbara D'Angelo, et al.
International Journal of Hematology
|
January 18, 2026
Three-year follow-up of epcoritamab therapy in Japanese patients with relapsed/refractory follicular lymphoma in EPCORE NHL-3
Koji Izutsu, Daigo Akahane, Tomomi Toubai, et al.
Leukemia & Lymphoma
|
July 9, 2025
Subcutaneous epcoritamab monotherapy in Japanese patients with relapsed or refractory follicular lymphoma: primary results of the EPCORE NHL-3 trial
Koji Izutsu, Daigo Akahane, Tomomi Toubai, et al.
Journal of Cellular Physiology
|
May 13, 2016
Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs
Annamaria Cimini, Michele d'Angelo, Elisabetta Benedetti, et al.
International Journal of Clinical Oncology
|
May 28, 2025
Efficacy and safety of epcoritamab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma: 3-year follow-up from the EPCORE NHL-3 trial
Koji Izutsu, Takahiro Kumode, Junichiro Yuda, et al.
Annals of Hematology
|
February 3, 2026
Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial
Yasmin H Karimi, Chan Y Cheah, Michael Roost Clausen, et al.
Page
of 3